共 50 条
Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease
被引:16
|作者:
Khera, Angela J.
Chase, Janet W.
Salzberg, Michael
Thompson, Alexander J. V.
Kamm, Michael A.
机构:
[1] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
关键词:
inflammatory bowel disease;
constipation;
fecal incontinence;
behavioral treatment;
biofeedback;
QUALITY-OF-LIFE;
RANDOMIZED-CONTROLLED-TRIAL;
FUNCTIONAL GASTROINTESTINAL DISORDERS;
LONG-TERM EFFICACY;
IBS-LIKE SYMPTOMS;
BIOFEEDBACK THERAPY;
DYSSYNERGIC DEFECATION;
CLINICAL-ASSESSMENT;
SHOWS BIOFEEDBACK;
GLOBAL IMPRESSION;
D O I:
10.1093/ibd/izy344
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Background Patients with inflammatory bowel disease (IBD) often experience functional bowel symptoms despite achieving disease remission. Although behavioral treatment (bowel and pelvic floor muscle retraining) is effective for managing constipation or fecal incontinence in non-IBD patients, there is limited evidence for its efficacy in patients with quiescent inflammatory bowel disease. The aim of this study was to evaluate the outcome of gut-directed behavioral treatment, including pelvic floor muscle training, for symptoms of constipation or fecal incontinence in patients with IBD in disease remission. Methods The outcome of consecutive patients with IBD in remission and symptoms of constipation or fecal incontinence was evaluated. Patients referred to a multidisciplinary gastroenterology clinic underwent gut-directed behavioral treatment, including pelvic floor muscle training. The primary outcome was patient-reported rating of change in symptoms on a 7-point Likert scale at the completion of treatment. Results Forty IBD patients (median age, 35 years; 80% female; 24 Crohn's disease [CD], 12 ulcerative colitis [UC], 4 UC with ileoanal pouch) with ongoing symptoms of constipation (55%) or fecal incontinence (45%), despite drug therapy, were included. The median symptom duration at referral was 2 years. Thirty-five (87%) completed treatment with a median of 2 sessions. Improvement of 6 = much better or 7 = very much better was reported by 77% (17/22) with fecal incontinence and 83% (15/18) with constipation. Improvement occurred irrespective of IBD diagnosis, previous perianal fistulae, colorectal surgery, presence of an ileoanal pouch, or past obstetric trauma. Conclusions Behavioral treatment effectively improves functional gut symptoms in a large majority of patients who are in IBD disease remission and who have not responded to drug therapy.
引用
收藏
页码:620 / 626
页数:7
相关论文